Magic Mushrooms Canada

The legal status of Psilocybin mushrooms varies across countries. The UN 1971 Convention on Psychotropic Substances lists ingredients such as Psilocin and Psilocybin under Schedule I as drugs with a high potential for abuse and no recognized medical uses. However, Psilocybin mushrooms have demonstrated their numerous medicinal values in dozens of religions and cultures throughout the history of humankind. They have also been known to possess a significantly lesser potential for abuse compared to other Schedule I drugs.

Just recently, the drug Psilocybin has also exhibited its moderate yet encouraging potential in treating several mental disorders such as depression, anxiety, addiction, and post-traumatic stress.

Psychedelic mushrooms and Magic Mushrooms Canada

Psychedelic mushrooms contain Psilocybin, an illegal ingredient that is illegal to sell, produce, or possess in Canada, the only exception being approved medical research. However, looking at the increasing medical relevance of these mushrooms in recent times, the Canadian government is allowing people who are terminally ill to use Psychedelic mushrooms for the treatment of depression and other mental disorders. Health Canada is granting exemptions to promote the therapeutic drug's use among people without the fear of getting into legal troubles. Because of the several medical benefits they offer, Psychedelic mushrooms are now known as magic mushrooms Canada.

Canada's new exemption policy comes at a time when the world is witnessing some significant changes around the use of Psilocybin. While Washington DC voted to decriminalize Psychedelic mushrooms, Oregon voted to legalize therapies assisted by Psilocybin. Even the NASDAQ stock exchange saw the UK-based Psychedelic medicine company Compass Pathways valued at over 1 billion USD. The company's business is built around the use of Psilocybin for treating patients with various illnesses, mainly treatment-resistant depression.

Some More Benefits of Psilocybin

According to many researchers, a single dose of the drug Psilocybin can produce quick, considerable, and prolonged results in treating cancer-related depression and anxiety, leading to improved spiritual well-being and overall quality of life.

Doctors say that Psilocybin, found in Psychedelic or magic mushrooms Canada, is an effective alternative for traditional antidepressants that failed to treat symptoms like poor quality of life, increased suicide rates, anxiety, and depression that lead to lower survival rates. Psilocybin provides a helpful tool for relieving such symptoms by enhancing the effectiveness of psychotherapy.

Experts believe that Psilocybin makes the brain more active and receptive to new thought patterns and ideas. Also, it targets the brain's default mode network, which activates as a result of mind wandering and self-reflection. The default network becomes hyperactive in patients suffering from anxiety and depression, leading to deliberation, worry, and inflexible thinking. The drug Psilocybin appears to markedly shift activity in the brain's default network, helping people take a more balanced approach towards their life and behavior.

Health Canada Allows Health Professionals to Use Magic Mushrooms

After allowing a group of palliative care patients to use magic mushrooms to relieve suffering relating to mental ailments, Health Canada has now provided clearance to over a dozen healthcare professionals to use the psychedelic drug Psilocybin to develop therapies for the future. Health Canada has communicated that it has granted 16 exemptions to a select group of doctors, nurses, therapists, social workers, and health professionals.

What Does the Decision Mean?

The exemptions will allow these professionals to possess and use the drug Psilocybin for training and research without fearing prosecution under Canada's drug laws. The exemptions also permit health professionals to use Psychedelic mushrooms to develop remedial therapies.

Those granted exemptions include Psychiatrists from the University of Toronto, a community Psychiatrist from Hamilton, and health professionals from Calgary and British Columbia.

The exemptions will allow these medical professionals to familiarise themselves with the unusual and outlandish world of Psychedelic mushrooms, for which there is limited scientific literature available. It will enable health professionals to figure out and guide patients suffering from mysterious and Psychotic ailments on using Psilocybin and Psychedelic mushrooms in the best way. The exemptions are valid for one year.

However, the Canadian Health Ministry has clarified that the exemptions granted do not empower health professionals to prescribe or make available magic mushrooms Canada containing Psilocybin to any other individual apart from the patients for whom they are intended and approved. Health Canada also reiterated that the exemptions do not mean it has approved the use of any other drugs containing Psilocybin. Further, it also added that the decision to grant exemptions is purely for medical purposes and does not represent an opinion or endorsement on its part promoting the use of Psilocybin-assisted therapy or its safety, quality, and effectiveness.

Conclusion

The potential of magic mushrooms Canada in the treatment of terminally ill patients is tremendous. They can deliver a much more powerful impact than years of ineffective therapy and medication. The exemptions granted by the Canadian government will go a long way in busting the myths around the negative qualities of Psychedelic mushrooms while allowing health professionals to get well versed with their effectiveness.